{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:13:16Z","timestamp":1769191996720,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"USDA-ARS","award":["58-6408-2-0009"],"award-info":[{"award-number":["58-6408-2-0009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40360-017-0147-4","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T04:26:07Z","timestamp":1496377567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Inhibitors of ubiquitin E3 ligase as potential new antimalarial drug leads"],"prefix":"10.1186","volume":"18","author":[{"given":"Jagrati","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"key":"147_CR1","volume-title":"WHO Global Malaria Programme","author":"Organization WH","year":"2015","unstructured":"Organization WH. World malaria report 2015. In: WHO Global Malaria Programme. Geneva: World Health Organization; 2015."},{"key":"147_CR2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/parasite\/2014059","volume":"21","author":"S Sinha","year":"2014","unstructured":"Sinha S, Medhi B, Sehgal R. Challenges of drug-resistant malaria. Parasite. 2014;21:61.","journal-title":"Parasite"},{"key":"147_CR3","doi-asserted-by":"crossref","unstructured":"Ponts N, Yang J, Chung DW, Prudhomme J, Girke T, Horrocks P, Le Roch KG. Deciphering the ubiquitin-mediated pathway in apicomplexan parasites: a potential strategy to interfere with parasite virulence. PLoS One. 2008;3(6):e2386.","DOI":"10.1371\/journal.pone.0002386"},{"issue":"46","key":"147_CR4","doi-asserted-by":"crossref","first-page":"40320","DOI":"10.1074\/jbc.M111.238790","volume":"286","author":"N Ponts","year":"2011","unstructured":"Ponts N, Saraf A, Chung DW, Harris A, Prudhomme J, Washburn MP, Florens L, Le Roch KG. Unraveling the ubiquitome of the human malaria parasite. J Biol Chem. 2011;286(46):40320\u201330.","journal-title":"J Biol Chem"},{"issue":"8","key":"147_CR5","doi-asserted-by":"crossref","first-page":"e43477","DOI":"10.1371\/journal.pone.0043477","volume":"7","author":"DW Chung","year":"2012","unstructured":"Chung DW, Ponts N, Prudhomme J, Rodrigues EM, Le Roch KG. Characterization of the ubiquitylating components of the human malaria parasite\u2019s protein degradation pathway. PLoS One. 2012;7(8):e43477.","journal-title":"PLoS One"},{"issue":"5971","key":"147_CR6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1177319","volume":"327","author":"T Ito","year":"2010","unstructured":"Ito T, Ando H, Suzuki T, Ogura T, Hotta K, Imamura Y, Yamaguchi Y, Handa H. Identification of a primary target of thalidomide teratogenicity. Science. 2010;327(5971):1345\u201350.","journal-title":"Science"},{"issue":"7512","key":"147_CR7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature13527","volume":"512","author":"ES Fischer","year":"2014","unstructured":"Fischer ES, Bohm K, Lydeard JR, Yang H, Stadler MB, Cavadini S, Nagel J, Serluca F, Acker V, Lingaraju GM, et al. Structure of the DDB1-CRBN E3 ubiquitin ligase in complex with thalidomide. Nature. 2014;512(7512):49\u201353.","journal-title":"Nature"},{"issue":"7","key":"147_CR8","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nbt.1645","volume":"28","author":"M Aghajan","year":"2010","unstructured":"Aghajan M, Jonai N, Flick K, Fu F, Luo M, Cai X, Ouni I, Pierce N, Tang X, Lomenick B, et al. Chemical genetics screen for enhancers of rapamycin identifies a specific inhibitor of an SCF family E3 ubiquitin ligase. Nat Biotechnol. 2010;28(7):738\u201342.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"147_CR9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ccr.2010.08.010","volume":"18","author":"X Zeng","year":"2010","unstructured":"Zeng X, Sigoillot F, Gaur S, Choi S, Pfaff KL, Oh DC, Hathaway N, Dimova N, Cuny GD, King RW. Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell. 2010;18(4):382\u201395.","journal-title":"Cancer Cell"},{"key":"147_CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.pharmtox.48.113006.094723","volume":"49","author":"S Shangary","year":"2009","unstructured":"Shangary S, Wang S. Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy. Annu Rev Pharmacol Toxicol. 2009;49:223\u201341.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"13","key":"147_CR11","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1021\/jm060023+","volume":"49","author":"Y Lu","year":"2006","unstructured":"Lu Y, Nikolovska-Coleska Z, Fang X, Gao W, Shangary S, Qiu S, Qin D, Wang S. Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy. J Med Chem. 2006;49(13):3759\u201362.","journal-title":"J Med Chem"},{"issue":"6","key":"147_CR12","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1128\/AAC.01607-06","volume":"51","author":"JD Johnson","year":"2007","unstructured":"Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007;51(6):1926\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"15","key":"147_CR13","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.bmcl.2014.06.030","volume":"24","author":"S Manda","year":"2014","unstructured":"Manda S, Khan SI, Jain SK, Mohammed S, Tekwani BL, Khan IA, Vishwakarma RA, Bharate SB. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-beta-carbolines. Bioorg Med Chem Lett. 2014;24(15):3247\u201350.","journal-title":"Bioorg Med Chem Lett"},{"key":"147_CR14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12906-016-1122-0","volume":"16","author":"S Jain","year":"2016","unstructured":"Jain S, Jacob M, Walker L, Tekwani B. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads. BMC Complement Altern Med. 2016;16:131.","journal-title":"BMC Complement Altern Med"},{"key":"147_CR15","doi-asserted-by":"crossref","unstructured":"Jain SK, Sahu R, Walker LA, Tekwani BL. A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line. J Vis Exp. 2012;(70):1\u2013474.","DOI":"10.3791\/4054"},{"key":"147_CR16","unstructured":"Dahl EL. Institution: Department of Medicine. San Francisco: University of California San Francisco."},{"issue":"10","key":"147_CR17","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.00527-07","volume":"51","author":"EL Dahl","year":"2007","unstructured":"Dahl EL, Rosenthal PJ. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob Agents Chemother. 2007;51(10):3485\u201390.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"147_CR18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1128\/AAC.00892-07","volume":"52","author":"D Barthel","year":"2008","unstructured":"Barthel D, Schlitzer M, Pradel G. Telithromycin and quinupristin-dalfopristin induce delayed death in Plasmodium falciparum. Antimicrob Agents Chemother. 2008;52(2):774\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"147_CR19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/AAC.00808-06","volume":"51","author":"TN Ramya","year":"2007","unstructured":"Ramya TN, Mishra S, Karmodiya K, Surolia N, Surolia A. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. Antimicrob Agents Chemother. 2007;51(1):307\u201316.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"147_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1517\/14728222.2013.739158","volume":"17","author":"CD Goodman","year":"2013","unstructured":"Goodman CD, McFadden GI. Targeting apicoplasts in malaria parasites. Expert Opin Ther Targets. 2013;17(2):167\u201377.","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"147_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.canlet.2011.08.011","volume":"312","author":"C Chargari","year":"2011","unstructured":"Chargari C, Leteur C, Angevin E, Bashir T, Schoentjes B, Arts J, Janicot M, Bourhis J, Deutsch E. Preclinical assessment of JNJ-26854165 (Serdemetan), a novel tryptamine compound with radiosensitizing activity in vitro and in tumor xenografts. Cancer Lett. 2011;312(2):209\u201318.","journal-title":"Cancer Lett"},{"issue":"10","key":"147_CR22","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ctrv.2014.10.004","volume":"40","author":"MJ Duffy","year":"2014","unstructured":"Duffy MJ, Synnott NC, McGowan PM, Crown J, O\u2019Connor D, Gallagher WM. p53 as a target for the treatment of cancer. Cancer Treat Rev. 2014;40(10):1153\u201360.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"147_CR23","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/1535-7163.MCT-08-0063","volume":"7","author":"J Kitagaki","year":"2008","unstructured":"Kitagaki J, Agama KK, Pommier Y, Yang Y, Weissman AM. Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2. Mol Cancer Ther. 2008;7(8):2445\u201354.","journal-title":"Mol Cancer Ther"},{"key":"147_CR24","doi-asserted-by":"crossref","unstructured":"Stuhmer T, Arts J, King P, Page M, Bommert K, Leo E, Bargou RC. A first-in-class HDM2-inhibitor (JNJ-26854165) in phase I development shows potent activity against multiple myeloma (MM) cells in vitro and ex vivo. ASCO Meeting Abstracts. 2008;26(15_suppl):14694.","DOI":"10.1200\/jco.2008.26.15_suppl.14694"},{"issue":"10","key":"147_CR25","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1073\/pnas.0708917105","volume":"105","author":"S Shangary","year":"2008","unstructured":"Shangary S, Qin D, McEachern D, Liu M, Miller RS, Qiu S, Nikolovska-Coleska Z, Ding K, Wang G, Chen J, et al. Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci U S A. 2008;105(10):3933\u20138.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-017-0147-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T08:30:23Z","timestamp":1569400223000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-017-0147-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["147"],"URL":"https:\/\/doi.org\/10.1186\/s40360-017-0147-4","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,2]]},"article-number":"40"}}